Salomon & Ludwin »

Silverback Therapeutics shares owned by Salomon & Ludwin

Quarter-by-quarter ownership of Silverback Therapeutics (SPRY) shares owned by Salomon & Ludwin from 13F filings

Historical chart of Salomon & Ludwin investment in Silverback Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Silverback Therapeutics held by Salomon & Ludwin consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Silverback Therapeutics by Salomon & Ludwin

Quarter filed Position value Share count Share price at filing
2024-03-31 $29k 2.8k 10.22
2023-12-31 $11k 2.8k 3.78
2023-09-30 $11k 2.8k 3.78

More positions owned by Salomon & Ludwin

Ishares S&p 500 Growth Etf (IVW)
Technology Select Sector Etf (XLK)
Vanguard S&p 500 Etf Etf (VOO)
Ishares S&p 500 Value Etf (IVE)
Ishares Short Term Ntnl Etf (SUB)
Vanguard Ftse Developed Etf (VEA)
Ishares Core S&p Mid-cap Etf (IJH)
Ishares Msci Eafe Etf Etf (EFA)
Spdr S&p 500 Etf Etf (SPY)
Microsoft Corporation (MSFT)
Ishares S&p Mid Cap 400 Etf (IJK)
Vanguard High Dividend Etf (VYM)
Vanguard Short Term Etf (VGSH)
Spdr Fund Consumer Etf (XLY)
Ishares Russell 2000 Etf (IWM)

View all positions for Salomon & Ludwin

Top funds holding Silverback Therapeutics

Deerfield Management Company
RA Capital Management
OrbiMed Advisors
Sr One Capital Management
K2 Principal Fund
Franklin Resources
Vanguard Group
BlackRock
Nextech Invest
FMR
Geode Capital Management
Perceptive Advisors
Rubric Capital Management
Royce & Associates
Sio Capital Management

View all funds holding Silverback Therapeutics